Acciones Chinook Tyee Industry Ltd Toronto S.E.
Acciones
GBI.H
CA16961T2083
Farmacéuticos
Ventas 2021 | 453 mil 328 mil 308 mil | Ventas 2022 | - | Capitalización | 3,43 M 2,49 M 2,34 M |
---|---|---|---|---|---|
Resultado Neto 2021 | -3 M -2,18 M -2,04 M | Resultado Neto 2022 | -1 M -725 mil -681 mil | VE / Ventas 2021 | 24,5 x |
Deuda neta 2021 | 1,87 M 1,36 M 1,28 M | Deuda neta 2022 | 3,15 M 2,28 M 2,14 M | VE / Ventas 2022 | - |
P/E ratio 2021 |
-2,14
x | P/E ratio 2022 |
-1,79
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 74,11 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Investor Relations Contact | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Frank Otto
BRD | Director/Board Member | - | 11/05/22 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+39,33 % | 6013,88 M | |
-18,38 % | 4396,11 M | |
-9,17 % | 3167,65 M | |
+3,98 % | 3065,44 M | |
-3,41 % | 2507 M | |
+48,74 % | 1881,13 M | |
-4,82 % | 1730,85 M | |
-1,24 % | 1648,42 M | |
-8,96 % | 1576,81 M |